Anti-FGL1 antibody [EPR9937] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal FGL1 antibody. Carrier free. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
HFREP1, FGL1, Fibrinogen-like protein 1, HP-041, Hepassocin, Hepatocyte-derived fibrinogen-related protein 1, Liver fibrinogen-related protein 1, HPS, HFREP-1, LFIRE-1
- IP
Supplier Data
Immunoprecipitation - Anti-FGL1 antibody [EPR9937] - BSA and Azide free (AB249593)
This data was developed using ab170922, the same antibody clone in a different buffer formulation.
All lanes:
Immunoprecipitation - Anti-FGL1 antibody [EPR9937] (<a href='/en-us/products/primary-antibodies/fgl1-antibody-epr9937-ab170922'>ab170922</a>) at 1/1000 dilution
All lanes:
Immunoprecipitation pellet from Human fetal liver lysate using <a href='/en-us/products/primary-antibodies/fgl1-antibody-epr9937-ab170922'>ab170922</a> at 1/10. at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated antibody at 1/2000 dilution
Predicted band size: 36 kDa
Observed band size: ~50 kDa
true
- WB
Supplier Data
Western blot - Anti-FGL1 antibody [EPR9937] - BSA and Azide free (AB249593)
This data was developed using ab170922, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-FGL1 antibody [EPR9937] (<a href='/en-us/products/primary-antibodies/fgl1-antibody-epr9937-ab170922'>ab170922</a>) at 1/1000 dilution
Lane 1:
Human fetal liver lysate at 10 µg
Lane 2:
HepG2 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated antibody at 1/2000 dilution
Predicted band size: 36 kDa
true
Related conjugates and formulations (1)
-
Anti-FGL1 antibody [EPR9937]
Reactivity data
Product details
ab249593 is the carrier-free version of ab170922.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FGL1 modulates the immune system and maintains its homeostasis. It functions primarily as a ligand for the immune checkpoint receptor LAG-3. This FGL1-LAG-3 interaction inhibits T-cell activity leading to immune tolerance and helping prevent autoimmunity. FGL1 while not a part of a complex demonstrates significant standalone biological activity by affecting immune responses especially under pathological conditions.
Pathways
FGL1 integrates into the immune regulatory framework. It exerts its effects mainly through the immune checkpoint pathway impacting T-cell regulation. In addition to LAG-3 FGL1 interacts closely with the PD-1/PD-L1 pathway which is also important in checkpoint inhibition and immune evasion mechanisms. These pathways together orchestrate the immune surveillance system and play roles in maintaining immune equilibrium.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Bio-protocol 15:e5206 PubMed39959296
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com